Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Novartis
US Department of Justice
Boehringer Ingelheim
Harvard Business School
Daiichi Sankyo
Chubb
Mallinckrodt
Moodys
Accenture
Farmers Insurance

Generated: August 18, 2017

DrugPatentWatch Database Preview

Details for Patent: ► Subscribe

« Back to Dashboard

Which drugs does patent 6,054,482 protect, and when does it expire?


Patent ► Subscribe protects NEURONTIN and is included in three NDAs.

Protection for NEURONTIN has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

Summary for Patent: ► Subscribe

Title: Lactam-free amino acids
Abstract:The present invention concerns cyclic amino acids of formula ##STR1## substantially free from the lactam ##STR2## wherein n is an integer of from 4 to 6, a process for the preparation thereof, compositions containing the compounds and methods of using them.
Inventor(s): Augart; Helmut (Waldkirch, DE), Gebhardt; Uwe (Waldkirch, DE), Herrmann; Wolfgang (Merzhausen, DE)
Assignee: Godecke Aktiengesellschaft (Berlin, DE)
Application Number:08/377,618
Patent Claim Types:
see list of patent claims
Compound; Process; Composition; Dosage form;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Parke Davis
NEURONTIN
gabapentin
SOLUTION;ORAL021129-001Mar 2, 2000AARXYesYes► Subscribe► SubscribeY
Pfizer Pharms
NEURONTIN
gabapentin
CAPSULE;ORAL020235-001Dec 30, 1993ABRXYesNo► Subscribe► SubscribeY
Pfizer Pharms
NEURONTIN
gabapentin
CAPSULE;ORAL020235-002Dec 30, 1993ABRXYesNo► Subscribe► SubscribeY
Pfizer Pharms
NEURONTIN
gabapentin
CAPSULE;ORAL020235-003Dec 30, 1993ABRXYesYes► Subscribe► SubscribeY
Pfizer Pharms
NEURONTIN
gabapentin
TABLET;ORAL020882-001Oct 9, 1998ABRXYesNo► Subscribe► SubscribeY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Foreign Priority and PCT Information for Patent: ► Subscribe

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany39 28 183Aug 25, 1989

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cerilliant
Covington
Citi
Chubb
Deloitte
Moodys
McKinsey
Fuji
Express Scripts
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot